Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Close proximity to plaques is associated with presynaptic dystrophy and Aβ42 oligomers increase BACE1 levels in cultured neurons [48,49], thus implicating Aβ neurotoxicity in these processes.”
In the citing paper
“We recently determined that BACE1-YFP expressed from a doxycycline-inducible transgene lacking the endogenous 5′ UTR that controls BACE1 translation accumulates around plaques in an APP transgenic mouse similar to that observed in AD [48].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 4×
“To test this possibility, we used the two genetic approaches we employed before, GADD34 CA-AAV transduction and eIF2a S51A knockin mice, to reduce p-eIF2a levels in cerebral neurons of the 5XFAD transgenic (Tg) mouse model of amyloidosis [51].”
BackgroundMethodInfluentialSelf-citationCitron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · cited 1×
“Recently, a mutation in APP near the BACE1 cleavage site (A673T) was identified that protects against AD by reducing BACE1 cleavage of APP and Ab production [18].”
BackgroundReinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells
Vattem, K. M., & Wek, R. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400541101 · Cited by 1,696
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513 · cited 2×
“For example, the Swedish mutation (K670N, M671L) at the BACE1 cleavage site in APP makes APP a better BACE1 substrate, and thus increases BACE1 cleavage and raises total Ab generation to cause FAD [17].”
BackgroundLacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015 · cited 3×
“Ab42 oligomers were prepared as described in [58].”
BackgroundMethodLu, P. D., Harding, H. P., & Ron, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408003 · Cited by 1,006 · cited 1×
“oligomers were prepared from HFIP lyophilized recombinant Ab42, as described previously [43,51].”
MethodKoffie, R. M., Meyer-Luehmann, M., Hashimoto, T., Adams, K. W., Mielke, M. L., Garcia-Alloza, M., Micheva, K. D., Smith, S. J., Kim, M. L., Lee, V. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811698106 · Cited by 850 · cited 2×
“Previous studies suggest that a halo of Ab oligomers is present around the amyloid plaque [3], implying that neuritic dystrophy in close proximity to the plaque might arise from Ab oligomer-induced toxicity.”
BackgroundThe secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799
Self-citationThe genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605
Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562
γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?
Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512
Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608856200 · Cited by 436
Eimer, W. A., & Vassar, R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-2 · Cited by 425 · cited 1×
“These five mutations result in massive overproduction of Ab42, intraneuronal Ab42 accumulation, plaque deposition at 2 months, memory impairment at 4–5 months, and neuron loss starting at 6 months [51,66].”
BackgroundSelf-citationZhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4396-06.2007 · Cited by 365
Self-citationUryu, K., Chen, X.-H., Martinez, D., Browne, K. D., Johnson, V. E., Graham, D. I., Lee, V. M.-Y., Trojanowski, J. Q., & Smith, D. H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.018 · Cited by 360
Grimm, D., Kay, M. A., & Kleinschmidt, J. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00095-9 · Cited by 344 · cited 1×
“The helper plasmids used (pDP1, pDP2) [54] generated combined serotype of 1 and 2, which efficiently transduces neurons, and can be purified on a heparin column [55].”
BackgroundDepletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337 · cited 1×
“Several molecular pathways have been proposed to mediate the BACE1 elevation, such as caspase-3induced cleavage of the trafficking adaptor protein GGA3 leading to impaired lysosomal degradation of BACE1 [34,35], Cdk5 phosphorylation of transcription factor Stat3 [36], altered levels of microRNAs [37–41], increased tra…”
Velliquette, R. A., O'Connor, T., & Vassar, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2350-05.2005 · Cited by 254
Self-citationKandalepas, P. C., Sadleir, K. R., Eimer, W. A., Zhao, J., Nicholson, D. A., & Vassar, R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1152-3 · Cited by 240 · cited 4×
“In the brains of APP Tg mice and AD patients, high concentrations of BACE1 protein accumulate in swollen dystrophic neurites in very close proximity to amyloid plaques [22,24,26], suggesting that Ab itself is responsible for raising BACE1 levels [42].”
BackgroundInfluentialSelf-citationA New Pathogenic Mutation in the APP Gene (I716V) Increases the Relative Proportion of A 42(43)
Eckman, C. B., Mehta, N. D., Crook, R., Perez-tur, J., Prihar, G., Pfeiffer, E., Graff-Radford, N., Hinder, P., Yager, D., Zenk, B., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2087 · Cited by 236
Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase
Buggia-Prévot, V., Fernandez, C. G., Riordan, S., Vetrivel, K. S., Roseman, J., Waters, J., Bindokas, V. P., Vassar, R., & Thinakaran, G. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-1 · Cited by 214
Self-citationChami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168 · cited 1×
“In the brains of APP Tg mice and AD patients, high concentrations of BACE1 protein accumulate in swollen dystrophic neurites in very close proximity to amyloid plaques [22,24,26], suggesting that Ab itself is responsible for raising BACE1 levels [42].”
BackgroundDevi, L., & Ohno, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012974 · Cited by 140 · cited 1×
“Another group has reported that p-eIF2a levels are increased ,3and ,9-fold at 6 and 15–18 months of age, respectively [69].”
BackgroundBRI2 (ITM2b) Inhibits A Deposition In Vivo
Kim, J., Miller, V. M., Levites, Y., West, K. J., Zwizinski, C. W., Moore, B. D., Troendle, F. J., Bann, M., Verbeeck, C., Price, R. W., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0891-08.2008 · Cited by 120 · cited 1×
“First, we transduced GADD34 CA-AAV into the brains of 5XFAD mice using the somatic brain transgenesis technique, which results in expression of the AAV vector transgene throughout the brain for the life of the mouse [53,67,68].”
MethodUbiquitin Regulates GGA3-mediated Degradation of BACE1
Kang, E. L., Cameron, A. N., Piazza, F., Walker, K. R., & Tesco, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092742 · Cited by 111 · cited 1×
“Several molecular pathways have been proposed to mediate the BACE1 elevation, such as caspase-3induced cleavage of the trafficking adaptor protein GGA3 leading to impaired lysosomal degradation of BACE1 [34,35], Cdk5 phosphorylation of transcription factor Stat3 [36], altered levels of microRNAs [37–41], increased tra…”
BackgroundChen, G.-J., Xiong, Z., & Yan, Z. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-3 · Cited by 30
Research works printed but not linked: 40
- WL Klein, 2004, Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer’s disease, Neurobiol Aging, 25, 569, 10.1016/j.neurobiolaging.2004.02.010 · DOI · Paper page
- SH Yun, 2006, Amyloid-beta1–42 reduces neuronal excitability in mouse dentate gyrus, Neurosci Lett, 403, 162, 10.1016/j.neulet.2006.04.065 · DOI
- Akram A, Christoffel D, Rocher AB, Bouras C, Kovari E, et al. (2007) Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer’s disease. Neurobiol Aging. · DOI
- B Calabrese, 2007, Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein, Mol Cell Neurosci, 35, 183, 10.1016/j.mcn.2007.02.006 · DOI · Paper page
- H Zempel, 2012, Linking Amyloid-beta and Tau: Amyloid-beta Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton, Neurodegener Dis, 10, 64, 10.1159/000332816 · DOI · Paper page
- A Rovelet-Lecrux, 2006, APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nat Genet, 38, 24, 10.1038/ng1718 · DOI · Paper page
- K Sleegers, 2006, APP duplication is sufficient to cause early onset Alzheimer’s dementia with cerebral amyloid angiopathy, Brain, 129, 2977, 10.1093/brain/awl203 · DOI · Paper page
- J Hardy, 2002, The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- H Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch Neurol, 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
- R Li, 2004, Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer’s disease patients, Proc Natl Acad Sci U S A, 101, 3632, 10.1073/pnas.0205689101 · DOI · Paper page
- T O’Connor, 2008, Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis, Neuron, 60, 988, 10.1016/j.neuron.2008.10.047 · DOI · Paper page
- SJ Tyler, 2002, alpha- and beta-secretase: profound changes in Alzheimer’s disease, Biochem Biophys Res Commun, 299, 373, 10.1016/S0006-291X(02)02635-9 · DOI · Paper page
- KR Sadleir, 2012, Cdk5 protein inhibition and Abeta42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease, J Biol Chem, 287, 7224, 10.1074/jbc.M111.333914 · DOI · Paper page
- Y Wen, 2004, Increased beta-secretase activity and expression in rats following transient cerebral ischemia, Brain Res, 1009, 1, 10.1016/j.brainres.2003.09.086 · DOI · Paper page
- Y Tong, 2005, Oxidative stress potentiates BACE1 gene expression and Abeta generation, J Neural Transm, 112, 455, 10.1007/s00702-004-0255-3 · DOI · Paper page
- I Blasko, 2004, Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer’s disease beta-secretase (BACE-1), J Neural Transm, 111, 523, 10.1007/s00702-003-0095-6 · DOI · Paper page
- Y Wen, 2008, Transcriptional Regulation of beta-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing, Neuron, 57, 680, 10.1016/j.neuron.2008.02.024 · DOI · Paper page
- V Boissonneault, 2009, MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1, J Biol Chem, 284, 1971, 10.1074/jbc.M807530200 · DOI · Paper page
- MA Faghihi, 2010, Evidence for natural antisense transcript-mediated inhibition of microRNA function, Genome Biol, 11, R56, 10.1186/gb-2010-11-5-r56 · DOI · Paper page
- WX Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1, J Neurosci, 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
- Y Zong, 2011, miR-29c regulates BACE1 protein expression, Brain Res, 1395, 108, 10.1016/j.brainres.2011.04.035 · DOI · Paper page
- D De Pietri Tonelli, 2004, Translational regulation of BACE-1 expression in neuronal and non-neuronal cells, Nucleic Acids Res, 32, 1808, 10.1093/nar/gkh348 · DOI · Paper page
- S Lammich, 2004, Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region, EMBO Rep, 5, 620, 10.1038/sj.embor.7400166 · DOI
- M Mihailovich, 2007, Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5′ untranslated region, Nucleic Acids Res, 35, 2975, 10.1093/nar/gkm191 · DOI · Paper page
- GW Rogers Jr, 2004, Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation, Proc Natl Acad Sci U S A, 101, 2794, 10.1073/pnas.0308576101 · DOI · Paper page
- D Scheuner, 2001, Translational control is required for the unfolded protein response and in vivo glucose homeostasis, Mol Cell, 7, 1165, 10.1016/S1097-2765(01)00265-9 · DOI · Paper page
- CS Chan, 2011, HCN channelopathy in external globus pallidus neurons in models of Parkinson’s disease, Nat Neurosci, 14, 85, 10.1038/nn.2692 · DOI · Paper page
- Y Levites, 2006, Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice, J Neurosci, 26, 11923, 10.1523/JNEUROSCI.2795-06.2006 · DOI · Paper page
- Sorensen AT, Kanter-Schlifke I, Carli M, Balducci C, Noe F, et al. (2008) NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus. · DOI
- JP Mayginnes, 2006, Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR, J Virol Methods, 137, 193, 10.1016/j.jviromet.2006.06.011 · DOI
- SE Reed, 2006, Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors, J Virol Methods, 138, 85, 10.1016/j.jviromet.2006.07.024 · DOI · Paper page
- KR Patterson, 2011, Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease, J Biol Chem, 286, 23063, 10.1074/jbc.M111.237974 · DOI · Paper page
- I Novoa, 2001, Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha, J Cell Biol, 153, 1011, 10.1083/jcb.153.5.1011 · DOI · Paper page
- B He, 1996, The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1) 34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells, J Virol, 70, 84, 10.1128/JVI.70.1.84-90.1996 · DOI
- A Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease, Nature, 349, 704, 10.1038/349704a0 · DOI · Paper page
- R Sherrington, 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease, Nature, 375, 754, 10.1038/375754a0 · DOI · Paper page
- J Chu, 2012, Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice, Mol Neurodegener, 7, 1, 10.1186/1750-1326-7-1 · DOI
- L Devi, 2013, Deletion of the eIF2alpha Kinase GCN2 fails to rescue the memory decline associated with Alzheimer’s disease, PLoS One, 8, e77335, 10.1371/journal.pone.0077335 · DOI · Paper page
- L Devi, 2013, Mechanisms that lessen benefits of beta-secretase reduction in a mouse model of Alzheimer’s disease, Transl Psychiatry, 3, e284, 10.1038/tp.2013.59 · DOI · Paper page
- T Ma, 2013, Suppression of eIF2alpha kinases alleviates Alzheimer’s disease-related plasticity and memory deficits, Nat Neurosci, 16, 1299, 10.1038/nn.3486 · DOI · Paper page
Cited by
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
Vassar, R. (2014) · Alzheimer's Research & Therapy · doi:10.1186/s13195-014-0089-7 · Cited by 410
Self-citationSadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1558-9 · Cited by 294
Self-citationIshimura, R., Nagy, G., Dotu, I., Chuang, J. H., & Ackerman, S. L. (2016) · eLife · doi:10.7554/elife.14295 · Cited by 221
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
Rozpędek-Kamińska, W., Siwecka, N., Wawrzynkiewicz, A., Wojtczak, R., Pytel, D., Diehl, J. A., & Majsterek, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062108 · Cited by 84
Liebsch, F., Kulic, L., Teunissen, C., Shobo, A., Ulku, I., Engelschalt, V., Hancock, M. A., van der Flier, W. M., Kunach, P., Rosa-Neto, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10152-w · Cited by 68
Metadata
- Authors
- Sadleir, K. R., Eimer, W. A., Kaufman, R. J., Osten, P., & Vassar, R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-03
- Volume
- 9
- Issue
- 7
- Pages
- e101643
- ISSN
- 1932-6203
- Cited by
- 36
- References
- 32
- Language
- en
- Update notices
- correction (2014-10-14)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.